- >95%: Ideal for in vitro bioassays, in vivo biological activity tests, and Phase I and early Phase II clinical trials.
- >98%: Meets pharma-cGMP standards with defined impurity specifications, suitable for late Phase II, Phase III clinical trials, and commercial use.
This product is for scientific research only. It is a +99% pure lyophilized pharmacy grade powder in a sealed, sterile vial, with the total weight indicated on the label. Product appearance, label, seal, and cap colors may vary slightly from the images shown. Additional supplies are required.
AOD 9604 is a research peptide derived from a specific sequence of human growth hormone (hGH). It is designed to mimic the fat-reducing properties of hGH without affecting growth hormone receptors or altering IGF-1 levels. Widely studied for its potential effects on fat metabolism, AOD 9604 promotes lipolysis (fat breakdown) and inhibits lipogenesis (fat storage). With a strong safety profile demonstrated in research, it is a valuable compound for studies exploring obesity, metabolism, and related applications. Available for research purposes only.
